Celiac disease prevalence in patients with iron deficiency anemia of obscure origin

Derya Uçardağ1, Sefa Güliter, Ozcan Ceneli

  • 1Department of Internal Medicine, Kirikkale University, School of Medicine, Kirikkale.

Insights

Celiac disease is more common in Turkish patients with unexplained iron deficiency anemia. Early screening for celiac disease is recommended for these patients to improve diagnosis.

Area of Science:

  • Gastroenterology
  • Immunology
  • Hematology

Background:

  • Iron deficiency anemia is a common complication of celiac disease.
  • The prevalence of celiac disease in Turkish patients with unexplained iron deficiency anemia requires further investigation.

Purpose of the Study:

  • To determine the prevalence of celiac disease in Turkish patients presenting with iron deficiency anemia of obscure origin.
  • To evaluate the utility of serological screening for celiac disease in this patient population.

Main Methods:

  • Evaluated 1,486 patients with iron deficiency anemia for etiology, identifying 77 with unexplained anemia.
  • Tested sera from 77 patients and 119 controls for IgA and IgG anti-tissue transglutaminase (tTG) antibodies.
  • Performed endoscopic duodenal biopsies and classified findings using the Marsh criteria.

Main Results:

  • Anti-tTG antibodies were detected in 7.8% (IgA) and 3.9% (IgG) of patients with unexplained anemia.
  • Histopathologic findings consistent with celiac disease were present in 7.8% of patients versus 0.8% of controls (p=0.02).
  • A higher prevalence of celiac disease was observed in patients with unexplained iron deficiency anemia.

Conclusions:

  • Patients with iron deficiency anemia of obscure origin exhibit an increased prevalence of celiac disease.
  • Serological screening for celiac disease should be considered for early detection in patients with unexplained iron deficiency anemia.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...